557 related articles for article (PubMed ID: 12199620)
1. Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies.
Tapiero H; Ba GN; Couvreur P; Tew KD
Biomed Pharmacother; 2002 Jul; 56(5):215-22. PubMed ID: 12199620
[TBL] [Abstract][Full Text] [Related]
2. COX-2 inhibitors and metabolism of essential fatty acids.
Das UN
Med Sci Monit; 2005 Jul; 11(7):RA233-7. PubMed ID: 15990700
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: implications for the use of cyclooxygenase inhibitors.
Penglis PS; Cleland LG; Demasi M; Caughey GE; James MJ
J Immunol; 2000 Aug; 165(3):1605-11. PubMed ID: 10903770
[TBL] [Abstract][Full Text] [Related]
4. Polyunsaturated fatty acids and bovine interferon-tau modify phorbol ester-induced secretion of prostaglandin F2 alpha and expression of prostaglandin endoperoxide synthase-2 and phospholipase-A2 in bovine endometrial cells.
Mattos R; Guzeloglu A; Badinga L; Staples CR; Thatcher WW
Biol Reprod; 2003 Sep; 69(3):780-7. PubMed ID: 12724278
[TBL] [Abstract][Full Text] [Related]
5. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
6. Rate of vasoconstrictor prostanoids released by endothelial cells depends on cyclooxygenase-2 expression and prostaglandin I synthase activity.
Camacho M; López-Belmonte J; Vila L
Circ Res; 1998 Aug; 83(4):353-65. PubMed ID: 9721692
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory drugs in the 21st century.
Rainsford KD
Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2: a therapeutic target.
Turini ME; DuBois RN
Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462
[TBL] [Abstract][Full Text] [Related]
9. COX-1 and COX-2 in health and disease.
Adelizzi RA
J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S7-12. PubMed ID: 10643175
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).
Taketo MM
J Natl Cancer Inst; 1998 Nov; 90(21):1609-20. PubMed ID: 9811310
[TBL] [Abstract][Full Text] [Related]
11. Platelet and aorta arachidonic and eicosapentaenoic acid levels and in vitro eicosanoid production in rats fed high-fat diets.
Sanigorski AJ; Sinclair AJ; Hamazaki T
Lipids; 1996 Jul; 31(7):729-35. PubMed ID: 8827696
[TBL] [Abstract][Full Text] [Related]
12. An update on eicosanoids and inhibitors of cyclooxygenase enzyme systems.
Sharma S; Sharma SC
Indian J Exp Biol; 1997 Oct; 35(10):1025-31. PubMed ID: 9475035
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 biology.
Clària J
Curr Pharm Des; 2003; 9(27):2177-90. PubMed ID: 14529398
[TBL] [Abstract][Full Text] [Related]
14. Effects of polyunsaturated fatty acids on prostaglandin synthesis and cyclooxygenase-mediated DNA adduct formation by heterocyclic aromatic amines in human adenocarcinoma colon cells.
Moonen HJ; Dommels YE; van Zwam M; van Herwijnen MH; Kleinjans JC; Alink GM; de Kok TM
Mol Carcinog; 2004 Jul; 40(3):180-8. PubMed ID: 15224350
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological analysis of cyclooxygenase-1 in inflammation.
Smith CJ; Zhang Y; Koboldt CM; Muhammad J; Zweifel BS; Shaffer A; Talley JJ; Masferrer JL; Seibert K; Isakson PC
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13313-8. PubMed ID: 9789085
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
[TBL] [Abstract][Full Text] [Related]
17. Role of omega-3 polyunsaturated fatty acids on cyclooxygenase-2 metabolism in brain-metastatic melanoma.
Denkins Y; Kempf D; Ferniz M; Nileshwar S; Marchetti D
J Lipid Res; 2005 Jun; 46(6):1278-84. PubMed ID: 15772428
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 and prostate carcinogenesis.
Hussain T; Gupta S; Mukhtar H
Cancer Lett; 2003 Mar; 191(2):125-35. PubMed ID: 12618325
[TBL] [Abstract][Full Text] [Related]
19. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
[TBL] [Abstract][Full Text] [Related]
20. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
Bertolini A; Ottani A; Sandrini M
Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
